Search results
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 12 hours agoOne, dubbed Pneumovax 23, is for adults at least 50 years of age and children older than two who are...
Merck Wins US Approval for Pneumonia Vaccine to Rival Pfizer’s
Bloomberg· 1 day agoMerck & Co. won US approval for a pneumococcal vaccine that threatens to unseat one of Pfizer Inc.’s...
Kansas Attorney General Kris Kobach sues Pfizer for COVID-19 vaccine
WIBW Topeka· 1 day agoKansas Attorney General Kris Kobach on Monday morning announced he is suing Pfizer for what he said...
Voisard Asset Management Group Inc. Takes $86,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoVoisard Asset Management Group Inc. bought a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent ...
Pfizer Inc. (NYSE:PFE) Shares Sold by Public Employees Retirement System of Ohio
ETF DAILY NEWS· 5 days agoPublic Employees Retirement System of Ohio reduced its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 1.8% during the 4th quarter, HoldingsChannel reports. The ...
Pfizer gene therapy for Duchenne fails to meet goals of key trial
BioPharma Dive via Yahoo Finance· 6 days agoThe negative results from the Phase 3 study, called Ciffreo, come a little more than a month after ...
Raleigh Capital Management Inc. Sells 2,270 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 3 days agoRaleigh Capital Management Inc. cut its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 3.4% in the fourth quarter, according to the company in its most recent disclosure ...
Pfizer study finds Paxlovid ineffective against Long COVID despite federal research funds
22 WSBT South Bend· 7 days agoLong COVID is a chronic condition resulting from an initial infective with COVID-19, according to...
Childress Capital Advisors LLC Has $583,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 5 days agoChildress Capital Advisors LLC boosted its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.2% during the 4th quarter, according to its most recent 13F filing with the Securities ...
Most Americans approve of DEI, according to Post-Ipsos poll
Washington Post via Yahoo News· 9 hours agoA Supreme Court decision last year striking down affirmative action in college admissions unleashed...